February 13, 2008 — The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative, funded by the National Institute of Mental Health (NIMH), has selected and tested ...
In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
Uncovering how rare genetic changes disrupt brain signaling and structure, this landmark study sheds new light on the roots of schizophrenia and opens doors for future therapies. Study: Whole-exome ...
Doxycycline, a broad-spectrum antibiotic commonly used to treat infections and acne, may help reduce the risk for schizophrenia in high-risk adolescents, new research suggests. A Finnish registry ...
Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...
A research study has analyzed the relation between the genetic risk of having schizophrenia and mild subclinical traits in people of the general population. According to the study, the way the genetic ...
About 1% of Americans, or nearly 3.5 million people, are affected by schizophrenia — yet the mental disorder remains highly stigmatized and misunderstood, experts say. The reason, according to Brooke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback